Cognitive performance in schizophrenia patients assessed before and following the first psychotic episode

Schizophrenia Research

Volumn 65, Issue 2-3, 2003, Pages 87-94

  Caspi, Asaf ^a,b   Reichenberg, Abraham ^c   Weiser, Mark ^a,b   Rabinowitz, Jonathan ^d   Kaplan, Ze'ev ^e   Knobler, Haim ^f   Davidson Sagi, Noa ^a,b   Davidson, Michael ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d BAR ILAN UNIVERSITY   (Israel)

^e BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^f MEDICAL CORPS   (Israel)

Author keywords

Cognitive function; First episode; Premorbid; Schizophrenia

Indexed keywords

ADULT; APTITUDE; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; HUMAN; ISRAEL; MALE; MATHEMATICAL COMPUTING; MENTAL HEALTH; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHIZOPHRENIA;

EID: 0242720304     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(03)00056-2     Document Type: Article

References (62)

1. Addington J., Addington D., Maticka-Tyndale E. Cognitive functioning and positive and negative symptoms in schizophrenia. Schizophr. Res. 5:1991;123-134.
2. Albee G.W., Lane E.A., Reuter J.M. Childhood intelligence of future schizophrenics and neighborhood peers. J. Psychol. 58:1964;141-144.
3. Ambelas A. Preschizophrenics: adding to the evidence, sharpening the focus. Br. J. Psychiatry. 160:1992;401-404.
4. Andreasen N.C. Linking mind and brain in the study of mental illnesses: a project for a scientific psychopathology. Science. 275:1997;1586-1593.
5. Andreasen N.C., Dennert J.W., Olsen S.A., Damasio A.R. Hemispheric asymmetries and schizophrenia. Am. J. Psychiatry. 139:1982;427-430.
6. Aylward E., Walker E., Bettes B. Intelligence in schizophrenia: meta-analysis of the research. Schizophr. Bull. 10:1984;430-459.
7. Bilder R.M., Goldman R.S., Robinson D., Reiter G., Bell L., Bates J.A., Pappadopulos E., Willson D.F., Alvir J.M., Woerner M.G., Geisler S., Kane J.M., Lieberman J.A. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am. J. Psychiatry. 157:2000;549-559.
8. Bower E.M., Shellhamer T.A. School characteristics of male adolescents who later became schizophrenics. Am. J. Orthopsychiatr. 30:1960;712-729.
9. Cannon M., Caspi A., Moffitt T.E., Harrington H., Taylor A., Murray R.M., Poulton R. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch. Gen. Psychiatry. 59:2002;449-456.
10. Capleton R.A. Cognitive function in schizophrenia: association with negative and positive symptoms. Psychol. Rep. 78:1996;123-128.
11. Carver R.P. Measuring intellectual growth and decline. Psychol. Assess. 1:1989;175-180.
12. Censits D.M., Ragland J.D., Gur R.C., Gur R.E. Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study. Schizophr. Res. 24:1997;289-298.
13. Cornblatt B., Obuchowski M., Schnur D., O'Brien J.D. Hillside study of risk and early detection in schizophrenia. Br. J. Psychiatry, Suppl. 172:1998;26-32.
14. Crawford J.R., Besson J.A., Bremner M., Ebmeier K.P., Cochrane R.H., Kirkwood K. Estimation of premorbid intelligence in schizophrenia. Br. J. Psychiatry. 161:1992;69-74.
15. David A.S., Malmberg A., Brandt L., Allebeck P., Lewis G. IQ and risk for schizophrenia: a population-based cohort study. Psychol. Med. 27:1997;1311-1323.
16. Davidson M., Reichenberg A., Rabinowitz J., Weiser M., Kaplan Z., Mark M. Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am. J. Psychiatry. 156:1999;1328-1335.
17. Done D.J., Johnstone E.C., Frith C.D., Golding J., Shepherd P.M., Crow T.J. Complications of pregnancy and delivery in relation to psychosis in adult life: data from the British perinatal mortality survey sample. BMJ. 302:1991;1576-1580.
18. Done D.J., Crow T.J., Johnstone E.C., Sacker A. Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. BMJ. 309:1994;699-703.
19. Erlenmeyer-Kimling L., Cornblatt B. Biobehavioral risk factors in children of schizophrenic parents. J. Autism Dev. Disord. 14:1984;357-374.
20. Fish B. Neurobiologic antecedents of schizophrenia in children. Evidence for an inherited, congenital neurointegrative defect. Arch. Gen. Psychiatry. 34:1977;1297-1313.
21. Gal R. The selection, classification and placement process. A Portrait of the Israeli Soldier. 1986;77-96 Greenwood Press, Westport, CT.
22. Goldberg T.E., Weinberger D.R. Thought disorder, working memory and attention: interrelationships and the effects of neuroleptic medications. Int. Clin. Psychopharmacol. 10(Suppl. 3):1995;99-104.
23. Goldberg T.E., Karson C.N., Leleszi J.P., Weinberger D.R. Intellectual impairment in adolescent psychosis. A controlled psychometric study. Schizophr. Res. 1:1988;261-266.
24. Griffith J.J., Mednick S.A., Schulsinger F., Diderichsen B. Verbal associative disturbances in children at high risk for schizophrenia. J. Abnorm. Psychology. 89:1980;125-131.
25. Guy W. ECDEU Assessment Manual For Psychopharmacology. revised ed. 1976;National Institute of Mental Health: US Department of Health Education and Welfare, Rockville.
26. Harvey P.D., Howanitz E., Parrella M., White L., Davidson M., Mohs R.C., Hoblyn J., Davis K.L. Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites. Am. J. Psychiatry. 155:1998;1080-1086.
27. Harvey P.D., Moriarty P.J., Serper M.R., Schnur E., Lieber D. Practice-related improvement in information processing with novel antipsychotic treatment. Schizophr. Res. 46:2000;139-148.
28. Hoff A.L., Riordan H., O'Donnell D.W., Morris L., DeLisi L.E. Neuropsychological functioning of first-episode schizophreniform patients. Am. J. Psychiatry. 149:1992;898-903.
29. Hoff A.L., Sakuma M., Wieneke M., Horon R., Kushner M., DeLisi L.E. Longitudinal neuropsychological follow-up study of patients with first-episode schizophrenia. Am. J. Psychiatry. 156:1999;1336-1341.
30. Jones P., Rodgers B., Murray R., Marmot M. Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet. 344:1994;1398-1402.
31. Kay S.R., Opler L.A., Lindenmayer J.P. Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Res. 23:1988;99-110.
32. Kraepelin E. Robertson G.M. Dementia Praecox and Paraphrenia. 1919;E&S Livingstone, Edinburgh.
33. Kremen W.S., Buka S.L., Seidman L.J., Goldstein J.M., Koren D., Tsuang M.T. IQ decline during childhood and adult psychotic symptoms in a community sample: a 19-year longitudinal study. Am. J. Psychiatry. 155:1998;672-677.
34. Kremen W.S., Seidman L.J., Faraone S.V., Toomey R., Tsuang M.T. The paradox of normal neuropsychological function in schizophrenia. J. Abnorm. Psychology. 109:2000;743-752.
35. Kremen W.S., Seidman L.J., Faraone S.V., Tsuang M.T. Intelligence quotient and neuropsychological profiles in patients with schizophrenia and in normal volunteers. Biol. Psychiatry. 50:2001;453-462.
36. Kretschmer E. Physique and Character. 1921;Kegan Paul, London.
37. Lane E.A., Albee G.W. Childhood intellectual development of adult schizophrenics. J. Abnorm. Soc. Psychol. 67:1963;186-189.
38. Lezak M.D. Neuropsychological Assessment. 3rd ed. 1995;Oxford Univ. Press, New York.
39. Malmberg A., Lewis G., David A., Allebeck P. Premorbid adjustment and personality in people with schizophrenia. Br. J. Psychiatry. 172(308-313):1998;305-314.
40. Marcus J., Hans S.L., Auerbach J.G., Auerbach A.G. Children at risk for schizophrenia: the Jerusalem Infant Development Study. II. Neurobehavioral deficits at school age. Arch. Gen. Psychiatry. 50:1993;797-809.
41. McGlashan T.H. Early detection and intervention of schizophrenia: rationale and research. Br. J. Psychiatry, Suppl. 172:1998;3-6.
42. Meltzer H.Y., McGurk S.R. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr. Bull. 25:1999;233-255.
43. Mohamed S., Paulsen J.S., O'Leary D., Arndt S., Andreasen N. Generalized cognitive deficits in schizophrenia: a study of first-episode patients. Arch. Gen. Psychiatry. 56:1999;749-754.
44. Mojtabai R., Bromet E.J., Harvey P.D., Carlson G.A., Craig T.J., Fennig S. Neuropsychological differences between first-admission schizophrenia and psychotic affective disorders. Am. J. Psychiatry. 157:2000;1453-1460.
45. Nieuwenstein M.R., Aleman A., de Haan E.H. Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studies. Wisconsin Card Sorting Test. Continuous Performance Test. J. Psychiatr. Res. 35:2001;119-125.
46. Nopolus P., Flaum M., Arndt S., Andreasen N. Morphometry in schizophrenia revisited: height and its relationship to pre-morbid function. Psychol. Med. 28:1998;655-663.
47. Offord D.R. School performance of adult schizophrenics, their siblings and age mates. Br. J. Psychiatry. 125:1974;12-19.
48. Olin S.C., Mednick S.A., Cannon T., Jacobsen B., Parnas J., Schulsinger F., Schulsinger H. School teacher ratings predictive of psychiatric outcome 25 years later. Br. J. Psychiatry, Suppl. 172:1998;7-13.
49. Rabinowitz J., Reichenberg A., Weiser M., Mark M., Kaplan Z., Davidson M. Cognitive and behavioural functioning in men with schizophrenia both before and shortly after first admission to hospital. Cross-sectional analysis. Br. J. Psychiatry. 177:2000;26-32.
50. Rabinowitz J., De Smedt G., Harvey P.D., Davidson M. Relationship between premorbid functioning and symptom severity as assessed at first episode of psychosis. Am. J. Psychiatry. 159:2002;2021-2026.
51. Raven J. The raven progressive matrices: change and stability over culture and time. Cogn. Psychol. 41:2000;1-148.
52. Russel A.J., Munro J.C., Jones P.B., Hemsley D.R., Murray R.M. Schizophrenia and the myth of intellectual decline. Am. J. Psychiatry. 154:1997;635-639.
53. Schwartzman A.E., Douglas V.I. Intellectual loss in schizophrenia: part I. Can. J. Psychol. 16:1962;1-10.
54. Spitzer R.L., Williams J.B., Gibbon M., First M.B. The structured clinical interview for DSM-III-R (SCID). I: history, rationale, and description. Arch. Gen. Psychiatry. 49:1992;624-629.
55. Tamminga C.A., Buchanan R.W., Gold J.M. The role of negative symptoms and cognitive dysfunction in schizophrenia outcome. Int. Clin. Psychopharmacol. 13(Suppl. 3):1998;S21-S26.
56. Walker E., Lewine R.J. Prediction of adult onset schizophrenia from childhood home movies of the patients. Am. J. Psychiatry. 147:1990;1052-1056.
57. Watt N.F., Lubensky A.W. Childhood roots of schizophrenia. J. Consult. Clin. Psychol. 44:1976;363-375.
58. Weickert T.W., Goldberg T.E., Gold J.M., Bigelow L.B., Egan M.F., Weinberger D.R. Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Arch. Gen. Psychiatry. 57:2000;907-913.
59. Weinberger D.R. From neuropathology to neurodevelopment. Lancet. 346:1995;552-557.
60. Weinberger D.R. On the plausibility of "the neurodevelopmental hypothesis" of schizophrenia. Neuropsychopharmacology. 14:1996;1S-11S.
61. Yung A.R., McGorry P.D. The initial prodrome in psychosis: descriptive and qualitative aspects. Aust. N. Z. J. Psychiatry. 30:1996;587-599.
62. Yung A.R., Phillips L.J., McGorry P.D., McFarlane C.A., Francey S., Harrigan S., Patton G.C., Jackson H.J. Prediction of psychosis. A step towards indicated prevention of schizophrenia. Br. J. Psychiatry, Suppl. 172:1998;14-20.